Published: 8 December 2025

Compliance

Exemption for advertising unapproved medicines at medical conferences

Advertising of unapproved medicines is not permitted unless the provisions of Section 34AA of the Medicines Act 1981 are met. This section provides an exemption from the prohibition on advertising the availability of unapproved medicines under section 20(2)(c) of the Act. This exemption applies only in the context of medical conferences and associated trade shows.

What the exemption requires:

The organiser of a medical conference must notify the Director-General of Health at least 30 working days before the opening of the conference with the following information:

  • Confirmation that one or more medicines not approved under sections 20, 22D, or 23 of the Medicines Act 1981 will be advertised at the medical conference.
  • The dates the conference will open and close.
  • The location of the conference.
  • Whether the medicines have been approved by a recognised regulatory authority.
  • Whether applications for approval under sections 20, 22D, or 23 of Medicines Act 1981 have been submitted to the Director-General of Health.

Please complete the online form below and press the "submit" button.

QUESTION 1

QUESTION 2

QUESTION 3

QUESTION 4

When does the medical conference start and end?

 

QUESTION 5

Will there be one or more medicines not approved under sections 20, 22D, or 23 of the Medicines Act 1981 advertised at the medical conference?

 

QUESTION 6

Have any of these medicines been approved by a recognised regulatory authority?
*Recognised regulatory Authorities have not yet been established, please answer "No"

 

QUESTION 7 (Optional)*

QUESTION 8

Have any applications for approval under sections 20, 22D or 23 of the Medicines Act 1981 been submitted to the Director General of Health for any of these medicines? If so, please state.

 

QUESTION 9 (Optional)*

QUESTION 10 (Optional)*

QUESTION 11 (Optional)*

QUESTION 12

Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /